Trump to unveil new drug price deal with Regeneron amid affordability push
Summary
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
Description
Regeneron would be the 17th drug company to agree to lower its prices as part of the administration’s Most Favored Nation initiative.
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source